Rasagiline Mesylate
Brand name: Rasagiline Mesylate
Rank #482 of 500 drugs by total cost
$14.5M
Total Cost
47,985
Total Claims
$14.5M
Total Cost
1,518
Prescribers
$303
Cost per Claim
6,611
Beneficiaries
94,120
30-Day Fills
$9,576
Avg Cost/Provider
32
Avg Claims/Provider
About Rasagiline Mesylate
Rasagiline Mesylate (sold as Rasagiline Mesylate) was prescribed 47,985 times by 1,518 Medicare Part D providers in 2023, costing the program $14.5M. At $303 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 479 | Lanthanum Carbonate (Lanthanum Carbonate) | $14.7M | 13,783 |
| 480 | Mometasone Furoate (Mometasone Furoate) | $14.7M | 266,966 |
| 481 | Lorlatinib (Lorbrena) | $14.7M | 720 |
| 482 | Rasagiline Mesylate (Rasagiline Mesylate) | $14.5M | 47,985 |
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology